Morgan Stanley Kempharm, Inc Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Kempharm, Inc stock. As of the latest transaction made, Morgan Stanley holds 555,950 shares of KMPH stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

555,950

Previous 213,088 160.9%

Holding current value

$2.75 Million

Previous $1.05 Million 161.03%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	N/A	342,862 Added 160.9%	555,950 $2.75 Million
Q2 2025 Aug 15, 2025	BUY	N/A	1,240 Added 0.59%	213,088 $1.05 Million
Q1 2025 May 15, 2025	SELL	N/A	-45,375 Reduced 17.64%	211,848 $1.05 Million
Q4 2024 Feb 14, 2025	BUY	N/A	129,740 Added 101.77%	257,223 $1.27 Million
Q3 2024 May 14, 2025	BUY	N/A	64,844 Added 103.52%	127,483 $629,000

Q3 2024 Nov 14, 2024	BUY	N/A	64,844 Added 103.52%	127,483 $629,000
Q2 2024 May 14, 2025	SELL	N/A	-194,584 Reduced 75.65%	62,639 $309,000
Q2 2024 Oct 17, 2024	SELL	N/A	-27,488 Reduced 30.5%	62,639 $309,000
Q2 2024 Aug 14, 2024	SELL	N/A	-27,488 Reduced 30.5%	62,639 $309,000
Q1 2024 Oct 17, 2024	BUY	N/A	27,488 Added 43.88%	90,127 $445,000
Q1 2024 Aug 16, 2024	BUY	N/A	15,984 Added 21.56%	90,127 $445,000
Q1 2024 May 15, 2024	BUY	N/A	15,984 Added 21.56%	90,127 $445,000
Q4 2023 Aug 16, 2024	BUY	N/A	11,504 Added 18.37%	74,143 $366,000
Q4 2023 Feb 13, 2024	BUY	N/A	46,232 Added 165.64%	74,143 $366,000
Q3 2023 Nov 15, 2023	SELL	N/A	-23,539 Reduced 45.75%	27,911 $137,000
Q2 2023 Aug 14, 2023	BUY	$4.94 - $6.29 $16,124 - $20,530	3,264 Added 6.77%	51,450 $254,000
Q1 2023 May 15, 2023	BUY	$4.13 - $6.27 $155,767 - $236,479	37,716 Added 360.23%	48,186 $265,000
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $29,416 - $40,126	-7,140 Reduced 40.55%	10,470 $48,000
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $170,838 - $260,053	-37,964 Reduced 68.31%	17,610 $109,000
Q2 2022 Oct 27, 2022	BUY	$4.02 - $5.21 $165,632 - $214,662	41,202 Added 286.68%	55,574 $248,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $5.21 $165,632 - $214,662	41,202 Added 286.68%	55,574 $248,000
Q1 2022 Oct 27, 2022	SELL	$5.0 - $9.26 $206,010 - $381,530	-41,202 Reduced 74.14%	14,372 $72,000
Q1 2022 May 13, 2022	SELL	$5.0 - $9.26 $10,240 - $18,964	-2,048 Reduced 12.47%	14,372 $72,000
Q4 2021 Feb 14, 2022	SELL	$7.6 - $10.26 $206,948 - $279,379	-27,230 Reduced 62.38%	16,420 $143,000
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $380,628 - $580,981	43,650 New	43,650 $407,000

Others Institutions Holding KMPH

# of Institutions

178

Shares Held

36.6M

Call Options Held

4.73M

Put Options Held

1.25M

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account